Exposure to Maternal Cannabis Use Disorder Ups Risk for Youth Behavioral Disorders
MONDAY, March 24, 2025 -- Children exposed to maternal cannabis use disorder (CUD) during pregnancy and postpartum have an increased risk for later behavioral disorders, according to a study published online in the April issue of Psychiatry Research.
Abay Woday Tadesse, from the School of Population Health at Curtin University in Australia, and colleagues assessed the relationship between maternal CUD during pregnancy and postpartum periods and the risk for disruptive behaviors in offspring. The analysis included linked data from 222,604 mother-child pairs, with live births recorded from 2003 to 2005.
The researchers found significantly higher risks for disruptive behavioral disorders in children of mothers with CUD during the antenatal (risk ratio, 3.56), perinatal (risk ratio, 3.55), and postnatal (risk ratio, 2.95) periods versus nonexposed dyads.
"Cannabinoid ingredients can cross the placenta and enter breast milk, potentially affecting brain development," coauthor Rosa Alati, Ph.D., also from Curtin University, said in a statement. "This research provides critical evidence to help shape health policies aimed at minimizing harm."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
2010 to 2019 Saw Global Decline in Noncommunicable Disease Mortality
FRIDAY, Sept. 12, 2025 -- Noncommunicable disease (NCD) mortality decreased in most countries around the world from 2010 to 2019, according to a study published online Sept. 10 in...
Sex Differences Seen in Characteristics, Course of Schizophrenia, Bipolar Disorder
FRIDAY, Sept. 12, 2025 -- Significant sex differences are seen in the characteristics and course of schizophrenia (SZ) and bipolar disorder (BD), according to a study published...
No Adverse Neurodevelopmental Effects Seen From Inhaled Anesthesia in Children Under 2
THURSDAY, Sept. 11, 2025 -- For children younger than 2 years undergoing surgery, no adverse neurodevelopmental effects are seen with the addition of dexmedetomidine and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.